{"title":"抑制tlr9依赖性p38 MAPK信号通路可改善NOD/Ltj小鼠原发性Sjögren综合征的发病机制。","authors":"N Cao, H Shi, C Chen, L Zheng, C Yu","doi":"10.23812/21-154-L","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15084,"journal":{"name":"Journal of biological regulators and homeostatic agents","volume":"35 3","pages":"1103-1108"},"PeriodicalIF":0.8000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Inhibition of the TLR9-dependent p38 MAPK signaling pathway improves the pathogenesis of primary Sjögren's syndrome in the NOD/Ltj mouse.\",\"authors\":\"N Cao, H Shi, C Chen, L Zheng, C Yu\",\"doi\":\"10.23812/21-154-L\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15084,\"journal\":{\"name\":\"Journal of biological regulators and homeostatic agents\",\"volume\":\"35 3\",\"pages\":\"1103-1108\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2021-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biological regulators and homeostatic agents\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.23812/21-154-L\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biological regulators and homeostatic agents","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23812/21-154-L","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
期刊介绍:
Journal of Biological Regulators & Homeostatic Agents (IF 1.397) is a peer-reviewed journal published every 2 months. The journal publishes original papers describing research in the fields of experimental and clinical medicine, molecular biology, biochemistry, regulatory molecules, cellular immunology and pharmacology.